CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to commercialize a novel technology for early detection of pancreatic cancer using circular DNA biomarkers. It focuses on validating the technology and developing a business plan to enhance diagnostic capabilities and improve patient outcomes.
Despite significant advancements in cancer therapy, the inadequate diagnosis and prognosis of many common cancers continue to limit the full potential of life-saving treatments.
This gap is particularly evident in the case of pancreatic ductal adenocarcinoma (PDAC), where late-stage diagnosis, coupled with limited treatment options, results in a mere 12% five-year survival rate for patients.
To improve survival rates, innovative technologies that facilitate early detection are urgently needed. I…
KOBENHAVNS UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, KØBENHAVN Ø
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
